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Burkholderia pseudomallei is the causative agent of melioidosis, a disease with high mor-
tality that is prevalent in tropical regions of theworld. A key component of the pathogenesis
of melioidosis is the ability of B. pseudomallei to enter, survive, and replicate within mam-
malian host cells. For non-phagocytic cells, bacterial adhesins have been identiﬁed both on
the bacterial surface and associated withType 4 pili. Cell invasion involves components of
one or more of the threeType 3 Secretion System clusters, which also mediate, at least in
part, the escape of bacteria from the endosome into the cytoplasm, where bacteria move
by actin-basedmotility.Themechanism of actin-basedmotility is not clearly understood, but
appears to differ from characterized mechanisms in other bacterial species. A small propor-
tion of intracellular bacteria is targeted by host cell autophagy, involving direct recruitment
of LC3 to endosomes rather than through uptake by canonical autophagosomes. How-
ever, the majority of bacterial cells are able to circumvent autophagy and other intracellular
defense mechanisms such as the induction of inducible nitric oxide synthase, and then
replicate in the cytoplasm and spread to adjacent cells via membrane fusion, resulting in
the formation of multi-nucleated giant cells. A potential role for host cell ubiquitin in the
autophagic response to bacterial infection has recently been proposed.
Keywords: melioidosis, Burkholderia, pathogenesis, adhesion, intracellular survival, autophagy, ubiquitination
INTRODUCTION
Burkholderia pseudomallei is a Gram-negative pathogen which is
the causative agent of melioidosis, a serious invasive disease of
humans and animals. Melioidosis is endemic to northern Aus-
tralia, Papua New Guinea, Southeast Asia, most of the Indian
subcontinent and southern China, Hong Kong, and Taiwan. It is
well recognized that B. pseudomallei is “highly endemic” to north-
east Thailand, northern Australia, Singapore, and Malaysia where
many cases of melioidosis are diagnosed each year (Currie et al.,
2008). Sporadic cases have also been reported in other regions
including Brazil, Puerto Rico, and New Caledonia (Dorman et al.,
1998; Aardema et al., 2005; Le Hello et al., 2005; Barth et al., 2007).
B. pseudomallei is a natural inhabitant of rice paddies, still or stag-
nant waters, and moist tropical soils (Brett and Woods, 2000).
Despite several decades of research on prevention and treatment,
mortality from melioidosis remains very high (50% in north-
east Thailand and 19% in Australia; Peacock, 2006). Alarmingly,
the mortality associated with septic shock remains close to 90%
(Stone, 2007). Melioidosis accounts for 20% of all community-
acquired septicemias in northeast Thailand (Chaowagul et al.,
1989) and 32% of community-acquired bacteremic pneumonia
and 6% of all bacteremias in northern Australia (Douglas et al.,
2004).
Since the 1990s, it has been well accepted that a key component
of the pathogenesis of B. pseudomallei is its ability to survive intra-
cellularly in both phagocytic and non-phagocytic cells (Jones et al.,
1996). The importance of intracellular survival is paramount, as
this remarkable feature allows the bacterium to establish an infec-
tion while avoiding host immune responses. Indeed, the ability
of B. pseudomallei to survive intracellularly explains numerous
features of melioidosis, including latency, recrudescence,and treat-
ment difﬁculty. Latency periods of more than 60 years have been
documented (Ngauy et al., 2005). Activation of a latent infection is
usually due to a decrease in the individual’s immunocompetence
and can result in an acute, fulminant, and fatal infection (Koponen
et al., 1991). Relapse is common in melioidosis patients; recrude-
scence of melioidosis following apparent clinical resolution of the
primary infection usually results from reactivation rather than
reinfection (Haase et al., 1995; Maharjan et al., 2005).
Burkholderia pseudomallei utilizes numerous strategies that
enable it to survive in such a specialized niche as the intracellular
environment (Figure 1). This review will focus on these strategies
for intracellular survival, from adhesion, invasion, and endosome
escape to actin-based motility, formation of multi-nucleated giant
cells (MNGC), evasion of host cell autophagy, and interaction of
B. pseudomallei with host cell ubiquitination mechanisms.
THE ADHESION OF B. PSEUDOMALLEI TO HOST CELLS: AN
EARLY STEP IN PATHOGENESIS
It is a sine quanon that the internalizationof pathogenic bacteria by
mammalian cells is preceded by adhesion of the bacteria to the cell
surface. It is therefore somewhat surprising that a detailed knowl-
edge at the molecular level of the interaction of B. pseudomallei
with the eukaryotic cell surface is less developed than that formany
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FIGURE 1 | Schematic representation of selected steps in the
intracellular lifestyle of B. pseudomallei. B. pseudomallei can be
internalized by either phagocytic or non-phagocytic cells. In
non-phagocytic cells PilA and the adhesins BoaA and BoaB are critical
for uptake. For the internalization step in non-phagocytic cells the Bsa
T3SS structural proteins BipD (translocator), BsaQ (structural component), and
BopE (effector) are required. The IrlRS two-component signal transduction
system is predicted to regulate the expression of other key gene(s) involved
in internalization. For internalization in phagocytic cells the BsaT3SS putative
effector BopA and the alternate sigma factor RpoS play minor roles. The Bsa
T3SS structural proteins BsaZ, BsaQ, and BsaU, the translocator protein BipD
and the putative effector BopA are critical for membrane disruption and
escape from the endocytic vesicle. Once in the cytoplasm B. pseudomallei
can replicate and move by actin-based motility in a BimA-dependent fashion.
B. pseudomallei LPS only weakly stimulates IFN secretion, which results in
reduced iNOS expression and NO production. Furthermore,
B. pseudomallei induces expression of suppressor of cytokine signaling 3
(SOCS3) and cytokine-inducible Src homology 2-containing (CIS)
proteins which inhibit the Janus kinases – signal transducers and
activators of transcription (JAK–STAT) signaling pathway and concomitant
iNOS activation. Purine (PurM, PurN), histidine (HisF), and
para-aminobenzoate (PabB) biosynthetic pathways are important for
intracellular replication and survival, while the B. pseudomallei T6SS-1 Hcp
protein, the alternate sigma factor RpoS, and the BsaT3SS protein BipB are
involved in stimulating cell-to-cell fusion and the formation of MNGC. NOD2
refers to nucleotide-binding oligomerization domain-containing protein 2.
Green arrows are used to indicate progression of time. RedT-bar arrows
indicate inhibitory interactions. Secretion system components are color coded
with effectors in purple, translocators in black, and structural components in
red.
other bacterial pathogens. Comparisons between different studies
using B. pseudomallei are difﬁcult because of the use of different
cell lines, bacterial strains, multiplicities of infection, and experi-
mental conditions by different research groups. Nevertheless, the
ability to adhere to the cell has been demonstrated to correlate
with virulence in a number of studies. Five B. pseudomallei strains
all adhered more strongly to human A549 lung epithelial cells
than did ﬁve strains of the non-pathogenic species B. thailandensis
(Kespichayawattana et al., 2004). The increased adhesion corre-
lated with subsequent increased invasion and cytopathic effect,
but, as in many other studies, the molecular basis for the dif-
ference was not determined. Likewise, a study which inferred,
through inhibition studies, the attachment of B. pseudomallei to
the GM1–GM2 glycosphingolipid ganglioside on undeﬁned pri-
mary human pharyngeal epithelial cells did not investigate the
bacterial component(s) involved (Gori et al., 1999).
Based on limited evidence derived from electron microscopy
(EM), Ahmed et al. (1999) suggested that the adhesion of B.
pseudomallei to an undeﬁned population of primary human“pha-
ryngeal” cells involved a bacterial surface structure which was
designated, without supporting evidence, as capsular polysaccha-
ride. Paradoxically, a more recent study with a genetically deﬁned
acapsular mutant (Reckseidler et al., 2001) found that the lack of
capsule resulted in enhanced internalization into A549 and HeLa
cells (Phewkliang et al., 2010); there was no effect on intracellular
replication or cytotoxicity. Thus, while capsule clearly plays a key
role in the ability of B. pseudomallei to cause disease (Reckseidler
et al., 2001; Lazar Adler et al., 2009), there is no clear evidence for
a role in cell adhesion or invasion (Table 1).
Type 4 ﬁmbriae (pili) are known to be involved in the adhesion
of a largenumberof bacterial species to a rangeof cell types, tissues,
and other surfaces (Pelicic, 2008). Consequently, these hair-like ﬁl-
aments, or their individual protein components, frequently consti-
tute key adhesins that may be necessary for virulence. In common
with many Gram-negative species,B. pseudomallei, produces Type
4pili. Inactivationof the pilA gene,which encodes thepilin subunit
protein, abrogated the production of pili and resulted in reduced
adhesion of B. pseudomallei to three different human epithelial cell
lines, including A549 cells (Essex-Lopresti et al., 2005). Interest-
ingly, adhesion to A549 and BEAS2-B cells was almost completely
abolished, consistent with pili being a major bacterial adhesin,
whereas adhesion of the pilA mutant to RPMI-2650 cells was
approximately 30% that of the wild-type, suggesting the presence
of additional adhesins (Table 1). The basis for these differences
remains unknown. The pilA gene can be regulated in response to
temperature,with up-regulation at lower temperatures (27–30˚C).
However, a pilA B. pseudomallei mutant showed reduced adhesion
to ME-180 cells derived from human cervical tissue (Table 1).
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Interestingly, PilA does not mediate direct adherence of B. pseudo-
mallei strain 08 to eukaryotic cells. Rather, up-regulation of pilA at
lower temperatures is responsible for the formation of B. pseudo-
mallei microcolonies. Thesemicrocolonies in turn display a higher
level of adherence to eukaryotic cells (Boddey et al., 2006). How-
ever, temperature regulation was not observed in strain K96243,
the ﬁrst strain to have its genome sequenced. Adhesion to six dif-
ferent human epithelial cell lines by strain 08 was also enhanced at
30˚C, but the role of pili was not investigated (Brown et al., 2002).
These studies again highlight the need for caution in extrapolat-
ing data derivedwith differentB. pseudomallei strains anddifferent
eukaryotic cell lines.
Flagellum-mediated adhesion was a prerequisite for invasion
of the free-living ameba Acanthamoeba astronyxis (Inglis et al.,
2003). However, a deﬁned aﬂagellar ﬂiC mutant was markedly
attenuated in BALB/c mice, but was unimpaired in its ability to
invade A549 cells (Chua et al., 2003; Table 1). These ﬁndings sug-
gest that ﬂagellae are required for virulence in mice, but probably
do not constitute a major adhesin for mammalian cells.
A recent study identiﬁed two novel adhesins in B. pseudoma-
llei (Balder et al., 2010). The BoaA protein shares similarity with
the YadA autotransporter adhesin of Yersinia enterocolitica and is
present also in B. mallei. Recombinant BoaA expressed in E. coli
enhanced the adhesion of E. coli to A549 and Hep2 cells, while
inactivation of the boaA gene reduced, but did not abolish, adhe-
sion of B. pseudomallei to both cell lines (Table 1; Figure 1). A
second related gene, boaB, appears to be unique to B. pseudoma-
llei. Expression of BoaB in E. coli also increased adhesion to A549
and Hep2 cells and mutation of boaB reduced adhesion to epithe-
lial cell lines (Table 1; Figure 1). Signiﬁcantly, a similar phenotype
was observed with cultured normal human bronchial epithelium.
Adouble boaA/boaB mutant exhibited levels of adhesion similar to
those of either single mutant, with some residual binding remain-
ing (Table 1). These ﬁndings suggest that multiple adhesins are
involved in the adhesion of B. pseudomallei to eukaryotic cells.
Moreover, different adhesins may be involved in the interaction of
bacteria with different cell types.
INTRACELLULAR INVASION, ESCAPE FROM ENDOCYTIC
VESICLES, AND SURVIVAL WITHIN THE CYTOPLASM
It is likewise a widely accepted notion that initial adherence of
pathogenic bacteria to the external surface of host cells is followed
immediately by intracellular invasion. Over the last decade, the
pace of research addressing howB. pseudomallei gains access to the
intracellular environment and how it subsequently escapes from
endocytic vesicles into the cytoplasm has accelerated, providing
much needed insight into this critical step of pathogenesis. Despite
this knowledge, a comprehensive understanding of the precise
mechanism of intracellular invasion and subsequent endosomal
escape is still lacking.
ENTRY INTO HOST CELLS
Burkholderia pseudomallei is taken up by phagocytic cells such
as polymorphonuclear leukocytes (Pruksachartvuthi et al., 1990;
Egan and Gordon, 1996; Jones et al., 1996) and macrophages
(Pruksachartvuthi et al., 1990; Harley et al., 1994, 1998b; Jones
et al., 1996; Kespichayawattana et al., 2000; Utaisincharoen et al.,
2001) and can invade non-phagocytic cell lines such as HeLa,
CHO, A549, and Vero cultured epithelial cell lines (Jones et al.,
1996; Harley et al., 1998a; Kespichayawattana et al., 2000). The
invasiveness of B. pseudomallei and its avirulent counterpart, B.
thailandensis, was compared in the human respiratory epithelial
cell line A549; the invasive capacity of B. pseudomallei was signif-
icantly greater than that of B. thailandensis (Kespichayawattana
et al., 2004).
AB. pseudomallei 1026b transposon mutagenesis screen identi-
ﬁed a gene encoding a putative two-component response regulator
that is involved in the invasionof the epithelial cell lineA549,HeLa,
and CHO cells, but not macrophages (Jones et al., 1997; Figure 1).
The transposon mutant exhibited an invasion level only 10% that
of the parental strain, 1026b, in epithelial cells. The disrupted
two-component response regulator was therefore named irlR for
invasion-related locus (Table 1). A putative two-component sen-
sor, irlS, was located downstream of the response regulator. This
irlRS two-component regulatory system is not involved in viru-
lence, as the mutant remained virulent in diabetic rats, hamsters
(Jones et al., 1997), and C57BL/6 mice (Wiersinga et al., 2008),
suggesting that the tissue culture invasion defect observed in vitro
was not related to pathogenesis in vivo.
Many diverse Gram-negative pathogenic bacteria use Type 3
Secretion Systems (T3SS) as a conserved, but highly adapted, vir-
ulence mechanism. The T3SS apparatus comprises approximately
20 different proteins assembled into a syringe-like structure that
spans the bacterial inner and outer membranes, enabling the
bacteria to secrete and inject effector molecules into the cytosol
of eukaryotic host cells for the subversion of cellular functions
(Hueck, 1998; Zhang et al., 2006; Sun and Gan, 2010). Although
the components of the T3SS apparatus are conserved between
species, the secreted proteins are highly divergent (Hueck, 1998).
B. pseudomallei encodes three T3SS clusters. Clusters 1 and 2 are
similar to the T3SS gene clusters encoding the Hrp secretons of the
plant pathogens Ralstonia (formerly Burkholderia) solanacearum
and Xanthomonas spp. (Winstanley et al., 1999; Rainbow et al.,
2002). However, cluster 3 shares homology to the inv/spa/prg T3SS
of Salmonella Typhimurium and the ipa/mxi/spa T3SS of Shigella
ﬂexneri (Attree and Attree, 2001; Stevens et al., 2001; Rainbow
et al., 2002) and has been designated the Burkholderia secretion
apparatus (bsa) T3SS (Stevens et al., 2002).
Numerous studies have demonstrated the importance of the
Bsa T3SS in the intracellular survival, replication, and virulence of
B. pseudomallei. Indeed, numerous structural components (BsaQ,
BsaU, and BsaZ), translocator (BipD), and effector proteins (BopA
and BopE) of the Bsa T3SS have been implicated in various aspects
of the intracellular lifecycle of B. pseudomallei, including inva-
sion of host cells, escape from endocytic vesicles, and intracellular
survival. Studies have shown that the invasion event requires the
proteins BopE, BipD (Stevens et al., 2003), and BsaQ (Muangsom-
but et al., 2008; Table 1; Figure 1). BopE shares similarity with
the Salmonella SopE/SopE2 effector proteins which act as guanine
nucleotide exchange factors (GEFs) for RhoGTPases that regulate
the actin network (Hardt et al., 1998; Rudolph et al., 1999; Sten-
der et al., 2000) and in turn facilitate bacterial invasion (Wood
et al., 1996; Bakshi et al., 2000). Likewise, BopE facilitates bacte-
rial invasion of non-phagocytic cells, as a B. pseudomallei 10276
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bopE mutant displayed a signiﬁcant reduction in invasion of HeLa
cells when compared to the wild-type strain (Stevens et al., 2003).
In turn, BopE induces rearrangements in the subcortical actin
cytoskeleton and also exhibits GEF activity. It was concluded that
in epithelial cells, BopE is likely to be translocated into the host
cell cytosol, where it may facilitate membrane rufﬂing by acting
as a GEF for Cdc42 and Rac1 (Stevens et al., 2003). This notion
is supported by a subsequent study by Upadhyay et al. (2008)
which showed that BopE and SopE/SopE2 catalytic domains adopt
similar three-dimensional folds, but that BopE has a more com-
pact conformation. An interaction of the catalytic domain of
BopE78–261 with Cdc42 was also demonstrated. Interestingly, the
SopE residues involved in contacting Cdc42 and the residues that
were shown by mutation to be functionally important in SopE are
conserved or conservatively substituted in BopE. Taken together,
these data suggest that BopE uses the same mechanism as SopE
and other Rho GEFs in catalyzing guanine nucleotide exchange in
Rho GTPases, despite the fact that BopE possesses a more closed
conformation (Upadhyay et al., 2008). The study performed by
Stevens et al. (2003) also provided evidence that BipD, a translo-
cator protein located on the tip of the needle (Johnson et al., 2007)
and similar to Salmonella SipD, is also involved in invasion of non-
phagocytic cells, as a 10276 bipD mutant was impaired in invasion
of HeLa cells and notably, to an even greater extent than the bopE
mutant described above, implying that several Bsa proteins may
act in concert with BopE to facilitate bacterial invasion (Stevens
et al., 2003; Stevens and Galyov, 2004).
BsaQ shares a high degree of identity with Salmonella
Typhimurium InvA (56%; Ginocchio and Galán, 1995) and there-
fore by analogy, BsaQ is most likely to be a conserved inner-
membrane channel protein, located at the base of the T3SS appa-
ratus (Muangsombut et al., 2008). A B. pseudomallei K96243 bsaQ
mutant exhibited a 30% reduction in invasion of A549 cells when
compared to wild-type B. pseudomallei (Muangsombut et al.,
2008). In turn, mutation of the bsaQ (Bsa structural component)
gene prevented the secretion of at least two T3SS proteins, BopE
and BipD (Muangsombut et al., 2008). Taken together, as it has
been shown that BopE and BipD are required for invasion of non-
phagocytic cells (Stevens et al., 2003), it can be speculated that
the impaired invasion efﬁciency exhibited by the bsaQ mutant is
a consequence of its inability to secrete the effector protein BopE
and the translocator BipD. Interestingly, BopE and BipD do not
appear to play a role in invasion of phagocytic cells, namely J774.2
murine macrophage-like cells, as bopE and bipD mutants were
taken up by J774.2 cells in comparable numbers to the wild-type
strain B. pseudomallei 10276 (Stevens et al., 2002). Likewise, we
have shown that BipD is not necessary for invasion of RAW 264.7
macrophage-like cells (Gong et al., 2011; Table 1). These data indi-
cate the importance of different T3SS mechanisms for the invasion
of non-phagocytic and phagocytic cells.
ESCAPE FROM ENDOCYTIC VESICLES
Once a bacterium gains access to the intracellular environment, it
must rapidly invoke strategies to survive within this niche.Accord-
ingly, within 15 min of internalization, B. pseudomallei strain
708a can escape from endocytic vesicles into the cytoplasm of
RAW 264.7, HeLa, and human macrophage-like U937 cells (MOI
of either 1000:1 or 100:1) by lysing endosome membranes thus
avoiding degradation through the lysosomal system (Harley et al.,
1998b). Several Bsa T3SS proteins play a role in escape of B.
pseudomallei from endocytic vesicles.
We have recently shown that the putative Bsa T3SS effector
protein BopA plays an important role in escape of B. pseudoma-
llei from phagosomes (Cullinane et al., 2008; Gong et al., 2011); a
bopA mutant displayed reduced intracellular survival and signiﬁ-
cantly increased co-localization with GFP–LC3 in RAW 264.7 cells
when compared to cells infected with wild-type K96243 (Table 1),
indicating the decreased ability of the mutant to escape from the
phagosome (Cullinane et al., 2008). The same mutant showed
reduced phagosomal escape compared towild-typewhen analyzed
by transmission electron microscopy (TEM); mutant bacteria that
were free in the cytoplasm however, could form actin-tails and
stimulate MNGC formation (Gong et al., 2011). These data indi-
cate that BopA is important for efﬁcient escape from phagosomes
(Figure 1). However, the mechanism by which BopA modu-
lates phagosomal escape is not known. Two possible functional
domains have been identiﬁed in BopA that may contribute to its
function in phagosomal escape. The ﬁrst is a carboxy-terminal
Rho GTPase inactivation domain (RID) which may function as
a protease or acyltransferase acting on host molecules (Pei and
Grishin, 2009). The second is a cholesterol binding domain (CBD;
Kayath et al., 2010). In macrophages infected with Mycobac-
terium avium, cholesterol depletion triggered phagolysosomal or
autophagolysosomal formation with consequent bacterial degra-
dation (de Chastellier and Thilo, 2006). Similarly, the binding of
cholesterol by BopA may lead to the accumulation of cholesterol
on phagosome membranes, thereby limiting lysosomal recogni-
tion and/or fusion. The function of both domains is amenable
to testing. Notably, BopA from B. mallei is important for inva-
sion and intracellular survival within J774A.1 macrophage cells;
a B. mallei bopA mutant showed reduced phagocytic uptake and
reduced intracellular survival (Whitlock et al., 2008). In murine
alveolar macrophage (MH-S) cells, a B. mallei bopA mutant was
recovered at higher levels from intracellular compartments com-
pared to wild-type B. mallei, suggesting that the bopA mutant
remains within intracellular compartments longer than wild-type,
resulting in decreased escape (Whitlock et al., 2009).
BsaZ, similar to Salmonella SpaS, is the last gene in the bsa gene
cluster that encodes a structural component of the T3SS apparatus
(Stevens et al., 2002). By examining the association of intracellu-
lar bacteria with lysosome-associated membrane glycoprotein-1
(LAMP-1) containing vacuoles, it has been shown that bsaZ and
bipD mutants are highly delayed in their ability to escape from
endocytic vesicles; 95.1 and 95.9% of bsaZ and bipD mutant bac-
teria respectively were LAMP-1 associated in J774.2 cells at 6 h
post-infection (p.i.; Stevens et al., 2002). Similarly, in analyses
usingTEM,the bsaZ mutantwas consistently observedonlywithin
vesicles with fully intact membranes (Stevens et al., 2002) and only
2% of bipD mutants were able to escape into the cytoplasm of
RAW 264.7 cells by 6 h p.i. (Gong et al., 2011; Table 1). A similar
study performed by Burtnick et al. (2008) also showed a phago-
some escape defect for a bsaZ mutant in activated RAW 264.7
murine macrophage-like cells. Using TEM analyses they demon-
strated that in concordance with results outlined by Stevens et al.
www.frontiersin.org August 2011 | Volume 2 | Article 170 | 7
Allwood et al. Burkholderia pseudomallei : intracellular survival
(2002) at 6 h p.i., the bsaZ mutant remained in endocytic vesicles;
however, by 12 h p.i. bacteria had begun to escape and by 18 h
p.i. the majority of mutant bacteria were located in the cytoplasm
(Burtnick et al., 2008). Thus, the bsaZ mutant does retain the abil-
ity to escape from endocytic vesicles, but this process is delayed by
6 to 12 h compared to the parent strain, DD503 (Burtnick et al.,
2008; Table 1; Figure 1).
In non-phagocytic A549 cells, a bsaQ mutant also showed
delayed escape from endocytic vesicles with 59.4% of mutant bac-
teria co-localizing with LAMP-1 positive vacuoles at 6 h p.i.; at
8 h p.i. further escape from vacuoles was observed (Muangsom-
but et al., 2008; Table 1; Figure 1). Likewise, a transposon mutant
which disrupted the gene bsaU (Bsa structural component),which
is thought to control needle length and whose product shares
∼20% similarity with Spa32 (Sun and Gan, 2010), was unable
to escape from endocytic vesicles 6 h after infection of HeLa cells
(Pilatz et al., 2006). The mutant however, retained the ability to
multiply within the vacuoles, resulting in the formation of large
vesicles containing many bacteria; at 12 h p.i. mutant bacteria
began to escape, indicating a delayed escape phenotype for this
mutant (Pilatz et al., 2006; Table 1; Figure 1).
The delayed escape phenotype observed for several Bsa T3SS
mutants suggests that mechanisms other than the Bsa T3SS may
be involved in escape from endocytic vesicles. It is noteworthy
to consider the possibility of “cross-talk” taking place between the
threeT3SS clusters inB. pseudomallei. Interestingly, a triplemutant
with stable deletions in the genes sctU1, sctU2, and bsaZ, which all
encode the putativemajor inner-membrane subunits of T3SS clus-
ters 1, 2, and 3 of B. pseudomallei, respectively, exhibited the same
delayed escape phenotype as the bsaZ mutant described above
(Burtnick et al., 2008; Table 1). This therefore provides evidence
that components of the T3SS-1 and T3SS-2 are not responsible for
the delayed escape phenotype observed for the bsaZ mutant and
that other factors are involved in delayed phagosomal escape in
RAW 264.7 cells (Burtnick et al., 2008). However, we have recently
shown that the T3SS cluster 1 predicted ATPase encoded by bpscN
is essential for full virulence of B. pseudomallei in a BALB/c
mouse infection model (D’Cruze et al., 2011). A bpscN mutant
was highly attenuated for virulence in BALB/c mice, displayed
reduced intracellular replication in RAW 264.7 macrophage-like
cells and increased co-localizationwith the autophagymarker pro-
tein LC3, but was unimpaired for escape from phagosomes. Thus,
the T3SS cluster 1 does play a role in the intracellular survival of
B. pseudomallei.
INTRACELLULAR SURVIVAL
Subsequent to invasion and escape from endocytic vesicles, the
ability of B. pseudomallei to survive intracellularly is important
for progression of infection. Screening of transposon mutants by
Pilatz et al. (2006) identiﬁed nine mutants with reduced ability to
formplaques on PtK2 cellmonolayers, indicating a reduced capac-
ity for intercellular spreading. Inactivation of bsaU and its role in
escape from endocytic vesicles has been discussed earlier in this
review. In addition to bsaU, Pilatz et al. (2006) showed that purine
(purM and purN ), histidine (hisF), and para-aminobenzoate
(pabB) biosynthetic pathway genes and bpsl1528 are all important
for intracellular replication and survival.
Neither purM, encoding a putative phosphoribosyl-formyl-
glycinamidine cyclo-ligase, nor purN, encoding a putative phos-
phoribosylglycinamide formyltransferase, were required for inva-
sionof HeLa cells; bothmutants displayedwild-type levels of cellu-
lar invasion. However, both purine biosynthesis pathway mutants
were defective for intracellular growth. Interestingly, the purM
mutant showed no intracellular replication during the course of
the experiment. Similarly, hisF (encoding a putative imidazole
glycerol phosphate synthase) and pabB (encoding a putative para-
aminobenzoate synthetase component) mutants also retained the
ability to invade HeLa cells, but were impaired for intracellular
growth. Although intracellular growth was impaired for purM,
purN, hisF, and pabB mutants, actin-tail formation, and the ability
to form membrane protrusions were not affected. These ﬁndings
contrast with those for a bpsl1528 mutant (encoding a putative
exported protein) that not only displayed severely restricted intra-
cellular growth in HeLa and J774A.1 macrophages, but was also
defective in formation of actin-tails and membrane protrusions.
RELEVANCE FOR IN VIVO PATHOGENESIS
While studies focusing on intracellular invasion, escape from
endocytic vesicles and subsequent intracellular replication and
survival using various deﬁned mutants have provided insight into
the pathogenesis of B. pseudomallei in an in vitro setting, it is crit-
ical to understand the role of the corresponding gene products
for in vivo pathogenesis. Numerous virulence studies have been
carried out and it appears that, with the exception of the bopE
(effector) mutant, a correlation exists between the in vitro inva-
sion and escape defects observed for various Bsa T3SS structural
component and translocator mutants, and their reduced ability
to cause disease. The bsaU transposon mutant, bsaZ and bipD
mutants described above were all attenuated in BALB/c mice fol-
lowing intranasal infection (Stevens et al., 2004; Pilatz et al., 2006).
The bipD mutant was also attenuated following intraperitoneal
infection and this correlated with reduced bacterial replication in
the liver and spleen (Stevens et al., 2004), suggesting a role for BipD
during both systemic and mucosal infection. A bsaZ triple mutant
(with deletions in the bsaZ homologs, sctU, in clusters 1 and 2 as
described above) was signiﬁcantly attenuated in hamsters; how-
ever, double and single mutants in sctU of clusters 1 and 2 that did
not share the cluster 3 bsaZ mutationwere not attenuated (Warawa
and Woods, 2005). However, a T3SS cluster 1 bpscN mutant was
attenuated in BALB/c mice (D’Cruze et al., 2011). Taken together,
these virulence data indicate that a functional Bsa T3SS apparatus
is required for full virulence of B. pseudomallei. Further, BipD and
therefore the Bsa T3SS, is functionally expressed during infection
in vivo, as antibodies against BipD have been detected in convales-
cent melioidosis patient sera (Stevens et al., 2002; Allwood et al.,
2008).
Interestingly, the bopE mutant was not attenuated in BALB/c
mice following either intraperitoneal or intranasal infection
(Stevens et al., 2004), indicating that the effector protein BopE,
on its own, is not essential for virulence and that other effectors
must play a role in subversion of normal cellular processes during
both systemic and mucosal infection. In turn,Warawa and Woods
(2005) also demonstrated that a bopE mutant and other putative
effector mutants (bopA, bapA, and bapC) were not attenuated for
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virulence in the acute hamster model. However, a bopA mutant
showed a mild attenuation in the BALB/c mouse model (Stevens
et al., 2004). It has been theorized that the B. pseudomallei Bsa
T3SS functions by delivering a set of effector proteins that tar-
get speciﬁc host cell pathways and that each individual effector
alone may actually contribute little to virulence; however, the con-
tribution of multiple effector proteins working in a cooperative
manner may have a signiﬁcant pathogenic impact (Galyov et al.,
2010). As such, the generation of double and/or triple effector
mutants would address this issue.
Similarly,a correlation also exists between the ability to replicate
intracellularly and the ability to cause disease. All mutants iden-
tiﬁed by Pilatz et al. (2006) that were defective for intracellular
growth (purM, purN, hisF, pabB, and bpsl1528) were also attenu-
ated for virulence in BALB/c mice following intranasal infection.
Interestingly, in the case of the purM, pabB, and bpsl1528 mutants,
all animals not only survived following challenge with 107 CFU,
but also showed no signs of disease (Pilatz et al., 2006). This study
therefore highlights the important role that the purine, histidine
and para-aminobenzoate biosynthetic pathways and bpsl1528 play
in pathogenesis.
Taken together, these data indicate the importance of numer-
ous genes and proteins involved in the intracellular life cycle of
B. pseudomallei, including those involved in T3SS and various
biosynthetic pathways. Importantly, the requirement for a func-
tional T3SS with the ability to secrete effector proteins is vital for
pathogenesis. Clearly, the secretion of numerous effector proteins
that function in a collaborative manner, rather than individually,
is critical for effective subversion of host cellular functions and
therefore for pathogenesis.
ACTIN-BASED MOTILITY: A CRUCIAL MECHANISM FOR
CELL-TO-CELL SPREAD
Members of several genera, including Burkholderia, Listeria,
Shigella,Rickettsia,andMycobacterium,have the remarkable ability
to propel themselves through the cytoplasm by polymerization of
the eukaryotic cytoskeletal protein actin at the surface of one pole
of the bacterium. The force generated by this actin-based motility
propels the bacterium through the cytoplasm, at speeds that range
from 3 to 87μm/min, depending on the pathogen and the cell
type (Stevens et al., 2006). This motility facilitates the formation
of membrane protrusions into neighboring cells and concomi-
tant cell-to-cell spread (Gouin et al., 2005; Stevens et al., 2006).
Since the late 1980s, an abundance of research has furthered the
understanding of how such intracellular pathogensmanipulate the
host actin polymerization machinery for their beneﬁt. Ultimately,
actin-based motility facilitates the avoidance of host innate and
adaptive immune responses as the pathogen spreads directly from
cell-to-cell.
THE Arp2/3 COMPLEX
The majority of pathogens capable of actin-based motility do so
by exploiting the Arp2/3 complex. This conserved host protein
complex consists of seven polypeptides and is involved in both
actin ﬁlament nucleation and organization (Cossart, 2000). On
its own, the Arp2/3 complex possesses weak biochemical activity.
The complex becomes activated by nucleation promoting factors
(NPFs),which includemembers of theWiskott–Aldrich syndrome
protein (WASP) family; this activation leads to a conformational
change in the complex (Welch andMullins, 2002;Goley et al., 2004;
Gouin et al., 2005; Goley and Welch, 2006). This change initiates
the formation of a new ﬁlament that emerges from an existing ﬁla-
ment, generating a y-branched actin network (Mullins et al., 1998;
Amann and Pollard, 2001; Goley and Welch, 2006). Intracellular
bacteria have developed a number of different mechanisms for
activating the Arp2/3 complex, thereby exploiting the complex for
their own beneﬁt. Research to date has identiﬁed two main strate-
gies. These mechanisms include either the expression of mimics of
the WASP family NPFs (e.g., Listeria monocytogenes ActA/Listeria
ivanovii IactA, or Rickettsia RickA), or surface proteins that func-
tion by recruiting host family WASP (N-WASP) proteins (e.g., S.
ﬂexneri IcsA; Welch et al., 1997, 1998; Egile et al., 1999; May et al.,
1999; Boujemaa-Paterski et al., 2001; Gouin et al., 2004, 2005; Jeng
et al., 2004). The expression of the bacterial protein,predominately
at one pole of the cell, therefore initiates actin polymerization by
direct or indirect activation of the Arp2/3 complex at the surface
of the pathogen (Stevens et al., 2005b).
BimA AND ITS ROLE IN ACTIN-BASED MOTILITY
Interestingly, it seems thatB. pseudomallei employs auniquemech-
anism for activation of actin-based motility. Initial evidence that
demonstrated the ability of B. pseudomallei to induce cellular actin
rearrangement andmembrane protrusions in both phagocytic and
non-phagocytic cells was provided by Kespichayawattana et al.
(2000). Actin rearrangement in a “comet” tail formation, typical
of actin-based motility, was observed at one pole of the bac-
terium after staining B. pseudomallei-infected J774A.1 and HeLa
cells with rhodamine-conjugated phalloidin. It was later discov-
ered that actin-based motility of B. pseudomallei is dependent
upon the autosecreted protein,BimA (Stevens et al., 2005b).Muta-
tion of bimA abolished actin-based motility of B. pseudomallei;
importantly however, the mutation did not inﬂuence the activity
of the Bsa T3SS and the mutant retained the ability to escape from
endosomes (Stevens et al., 2005b; Table 1; Figure 1). Evidence
supporting the notion that actin-based motility is a prerequisite
for intercellular spread was provided by Stevens et al. (2005b) and
Sitthidet et al. (2011). A bimA mutant did not form membrane
protrusions in J774.2 cells (Stevens et al., 2005b) and did not form
plaques in A549 monolayers (Sitthidet et al., 2011), indicating the
bimA mutant could not spread from cell-to-cell. Reminiscent of
ActA and IcsA, BimA was found to localize at one pole of the bac-
terial cell where actin assembly takes place (Stevens et al., 2005b).
Interestingly, BimA homologs in B. mallei and B. thailandensis
(which also possess the ability to induce actin-based motility in
J774.2 cells) can restore the actin-based motility defect of a B.
pseudomallei bimA mutant (Stevens et al., 2005a).
A survey of the prevalence and sequence diversity of BimA in
clinical and environmental isolates from endemic areas demon-
strated intraspecies conservation of BimA in natural populations
of B. pseudomallei, B. mallei, and B. thailandensis (Sitthidet et al.,
2008). In addition, tandem WASP homology 2 (WH2) domains,
which are predicted to mediate the binding of actin monomers,
were conserved in sequenced B. pseudomallei strains (Sitthidet
et al., 2008). These domains were later found to be required for
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actin binding, actin assembly, and therefore, actin-based motil-
ity (Sitthidet et al., 2011). A proline-rich motif (IP7, also known
as PRM1) which is known to interact with proﬁlin and func-
tions to funnel actin monomers to the tip of actin ﬁlaments,
was also conserved in sequenced B. pseudomallei strains. In addi-
tion, a tandem repeat of 13 amino acids adjacent to the IP7
motif on the amino-terminal side (NIPVPPPMPGGGA) was con-
served in most sequenced B. pseudomallei strains (Sitthidet et al.,
2008). However, later studies indicated that the 13 amino acid
repeat and the IP7 proline-rich motif are not essential for actin-
based motility in vitro (Sitthidet et al., 2011). The number of
PDASX repeats that are adjacent to the WH2 domains on the
carboxyl-terminal side was also found to vary within sequenced B.
pseudomallei strains, with the number of repeats ranging from
2, 5 to 7 copies (Sitthidet et al., 2008). It was demonstrated
that a tract of ﬁve PDASX direct repeats was required for actin-
based motility and intercellular spread; however, they were not
involved in actin binding. Interestingly, the rate of polymeriza-
tion increased in a stepwise manner as the number of PDASX
repeats increased from zero to two to ﬁve to seven, indicating
that these repeats act in an additive manner to stimulate poly-
merization of pyrene-actin monomers in vitro (Sitthidet et al.,
2011).
BURKHOLDERIA PSEUDOMALLEI EMPLOYS A UNIQUE MECHANISM
FOR ACTIVATION OF ACTIN-BASED MOTILITY
Burkholderia pseudomallei does not activate actin-based motil-
ity via a Shigella-like mechanism, as N-WASP is not found on
either the surface of B. pseudomallei or within actin-tails (Breit-
bach et al., 2003). This, and the fact that F-actin clustering results
fromtransient expressionof BimA,a characteristic that is seenwith
WASP overexpression (Stevens et al., 2005b), indicate that BimA
may function as an NPF mimic to induce actin-based motility
in infected cells (Stevens et al., 2006). However, the mechanism
appears distinct from that of Listeria, as VASP proteins were not
detected on the surface of B. pseudomallei and only very weakly
throughout actin-tails (Breitbach et al., 2003); this is in contrast
to Listeria where Ena/VASP proteins interact directly with ActA
(Laurent et al., 1999). Conﬁrmatory to these results, infection
of N-WASP- or Ena/VASP-defective cells with B. pseudomallei
demonstrated that these proteins are not essential for actin-based
motility by B. pseudomallei (Breitbach et al., 2003).
Interestingly, while the Arp2/3 complex is strongly incorpo-
rated into B. pseudomallei actin-tails (Breitbach et al., 2003), its
precise function in actin polymerization is not clear. BimA can
stimulate actin polymerization in vitro in an Arp2/3 independent
manner (Stevens et al., 2005b). In addition, overexpression of an
Arp2/3 binding WCA (WH2, central, and acidic) domain of Scar1
(NPF), which leads to cytoplasmic sequestration and inhibition of
the Arp2/3 complex, and therefore inhibition of motility of Lis-
teria, Shigella, and Rickettsia conorii, had no effect on actin-based
motility of B. pseudomallei (Breitbach et al., 2003). Based on these
data, it appears that the mechanism of actin-based motility of B.
pseudomallei is distinct from that identiﬁed for all other intracel-
lular pathogens studied to date. It has been suggested that BimA
alonemaybe sufﬁcient for intracellularmotility of B. pseudomallei;
however, the requirement for other bacterial co-factors or differ-
ent post-translational modiﬁcations of BimA cannot be ruled out
(Stevens et al., 2006).
A POTENTIAL ROLE FOR TYPE VI SECRETION SYSTEM CLUSTER 1 AND
OTHER GENE PRODUCTS IN ACTIN-BASED MOTILITY
The B. pseudomallei genome encodes six functional Type 6 Secre-
tion Systems originally designated T6SS-1-6 (Schell et al., 2007).
A subsequent paper by Shalom et al. (2007) however, assigned the
names tss-5, tss-4, tss-6, tss-3, tss-2, and tss-1, respectively, to these
same gene clusters. As such,we will refer to the nomenclature used
by Schell et al. (2007).
T6SS play a role in virulence in many bacterial pathogens where
they function to inject effector proteins into host cells (Pukatzki
et al., 2009). New evidence has demonstrated that in B. mallei,
the T6SS-1 plays an important role in actin-based motility in
RAW 264.7 cells; tssE mutants were able to undergo vacuolar
escape, but once in the cytoplasm the mutants exhibited defects
in actin polymerization and intra- and intercellular spread (Burt-
nick et al., 2010). Importantly, a homologous T6SS expressed in
B. pseudomallei is similarly induced following uptake by RAW
264.7 cells. This system (T6SS-1; locus tags BPSS1493–BPSS1511)
is ﬂanked by bimA on one side and the Bsa T3SS locus on the
other (Shalom et al., 2007). By analogy with B. mallei, it could
be speculated that mutation of T6SS-1 in B. pseudomallei would
also cause actin polymerization defects and raises the question
as to whether secreted effectors of the T6SS, such as Hcp and/or
VgrG, could interact with BimA. Importantly however, a T6SS-1
tssH mutant showed no difference in invasion and survival within
RAW 264.7 cells compared to wild-type B. pseudomallei; its abil-
ity to polymerize actin and undergo actin-based motility was not
investigated (Shalom et al., 2007). A subsequent study by Burt-
nick et al. (2011) has now shown that while a hcp1 (from T6SS-1)
mutant did demonstrate a slightly reduced level of actin-based
motility compared to wild-type B. pseudomallei, this difference
was not as signiﬁcant as that observed in the B. mallei tssE T6SS-1
mutant described above (Burtnick et al., 2010). tssE is predicted
to encode a component of the T6SS-1 apparatus and appears to
be required for Hcp1 secretion (Schell et al., 2007). Therefore, it
appears likely that tssE is required for secretion of other effector(s)
that may play a role in actin polymerization, as mutation of hcp1
on its own had little effect on actin-based motility. Interestingly
however, mutation of hcp1 resulted in the absence of MNGC for-
mation (discussed elsewhere in this review), delayed intracellular
growth, and reduced cytotoxicity in RAW 264.7 cells (Burtnick
et al., 2011).
Another gene which has been implicated for its potential
role in actin-tail formation is bpsl1528 which encodes a puta-
tive exported protein (Pilatz et al., 2006). As described above, a
bpsl1528 mutant was defective for intracellular growth; immuno-
ﬂuorescence microscopy revealed that actin-tail formation was
severely impaired as only rudimentary actin-tails were observed
and no protrusions could be detected in HeLa cells. However,
the mutant also demonstrated reduced swimming motility. Pilatz
et al. (2006) therefore speculated that the pleiotropic phenotype
of the bpsl1528 mutant may be due to a regulatory function of the
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encoded protein on numerous virulence factors rather than to a
single effector molecule.
In summary, the role of BimA in actin-based motility is widely
accepted. However, further evidence has indicated that the process
of actin polymerization leading to actin-based motility may occur
as a result of a concerted effort involving other bacterial factor(s)
that could involve the T6SS cluster 1 and other putative exported
proteins. Interestingly, the process of activation of actin-based
motility by B. pseudomallei is distinct from that observed for other
pathogens and further studies are therefore required to address this
issue.
CELL FUSION AND THE FORMATION OF MULTI-NUCLEATED
GIANT CELLS: IMPORTANT MECHANISMS FOR THE
PROGRESSION OF INFECTION
As outlined above, several species of intracellular pathogens are
able to move throughout the cell cytoplasm by manipulating actin
polymerization. For Shigella, actin-based motility is also sufﬁcient
for the movement of bacteria from cell-to-cell via membrane
protrusions (Monack and Theriot, 2001). Indeed, recombinant
E. coli cells expressing S. ﬂexneri IcsA (required for actin poly-
merization) were able to produce membrane protrusions in HeLa
cells and move into the cytoplasm of adjacent cells (Monack
and Theriot, 2001). While actin-based motility is an essential
prerequisite for the spread of B. pseudomallei from cell-to-cell
(Stevens et al., 2005b; Sitthidet et al., 2011), cell fusion, and the
production of MNGC also appears to be required. Infection of
phagocytic or non-phagocytic cell lines with B. pseudomallei, B.
mallei, or B. thailandensis results in cell-to-cell fusion and the for-
mation of MNGC (Harley et al., 1998a). Furthermore, MNGC
have also been observed following histopathological assessment
of human tissue samples recovered from melioidosis patients
(Wong et al., 1995), suggesting that MNGC formation occurs
during B. pseudomallei infection. Other infectious agents such as
human immunodeﬁciency virus (HIV; Ciborowski and Gendel-
man, 2006), cytomegalovirus (CMV;Kinzler and Compton, 2005),
herpes simplex virus (HSV; Cole and Grose, 2003), and mycobac-
terial species (Utermöhlen et al., 2008) also drive the formation of
MNGC.
Induction of cell fusion following B. pseudomallei infection
was conﬁrmed by analysis of co-cultures of J774A.1 cells that had
been labeled either with cell tracker green CMFDA or cell tracker
red CMTMR prior to mixing (Kespichayawattana et al., 2000).
Orange–yellow MNGC were observed within 4–6 h after infection,
indicating that some of the eukaryotic cell membranes had fused;
no fused cells were observed in mock infected cultures. Similar
results were obtained with HeLa and L929 cells, although the rate
of cell fusion and MNGC formation was slower. B. pseudomallei
infection leads to apoptosis of both fused and unfused cells. At
2 h p.i. approximately 3% of cells showed evidence of apoptotic
changes and this increased to 43% by 6 h. Interestingly, within
MNGC, both normal nuclei and those showing apoptotic changes
could be observed (Kespichayawattana et al., 2000).
The molecular mechanisms leading to cell fusion and for-
mation of MNGC following B. pseudomallei infection are
poorly characterized. Macrophage cell fusion may be associ-
ated with chronic inﬂammation and can be induced in vitro
by treatment of macrophages with certain cytokines, including
macrophage colony-stimulating factor, granulocyte–macrophage
colony-stimulating factor, interleukin (IL)-4 and IFN-γ (Kondo
et al., 2009). Cell fusion in response to infections with the viruses
CMV and HSV is associated with the production of viral glyco-
proteins (Cole and Grose, 2003; Kinzler and Compton, 2005). In
B. pseudomallei, the ability to form MNGC has been associated
with RpoS, BipB, T6SS-1, and the putative toxin-encoding genes
bpsl0590 and bpsl0591 (Figure 1).
A B. pseudomallei rpoS mutant could replicate intracellularly
almost indistinguishably from the wild-type strain, but was signif-
icantly impaired in its ability to induceMNGC formation; only 3%
of cells infected with the rpoS mutant formed MNGC compared
with 17% for cells infected with the wild-type strain (Utaisin-
charoen et al., 2006). However, the rpoS mutant was not tested for
its ability to move intracellularly by actin-based motility (Table 1).
The RpoS regulon in B. pseudomallei has been elucidated by com-
paring protein expression in wild-type and rpoS mutant strains;
70 proteins (derived from 58 unique genes) showed differential
expression of >3-fold (p < 0.05) between the two strains (Osiri-
phun et al., 2009). The proteins encoded by these differentially
expressed genes included bacterial stress response and cell enve-
lope biogenesis components as well as some putative virulence
factors, including a T3SS-1 component. Thus, it is likely that RpoS
regulates the expression of aB. pseudomallei gene(s) that is directly
involved in the stimulation of cell-to-cell fusion, but the exact
gene(s) has not yet been identiﬁed.
The Bsa T3SS and the effector protein BipB have also been
implicated in MNGC formation; a bipB mutant was unable to
induce MNGC formation in J774A.1 macrophage-like cells at 6 h
p.i. and showed 6 to 10-fold reduced MNGC formation at later
time-points (Suparak et al., 2005). The ability to form MNGC
was restored by complementation with intact bipB. However, it is
unclear if BipB is speciﬁcally involved in cell fusion and MNGC
formation, as the bipB mutant was also signiﬁcantly impaired for
invasion of HeLa cells and was not tested for its ability to move
intracellularly by actin-based motility (Table 1).
Hcp proteins are critical components of T6SS. B. pseudomallei
mutants with deletion of hcp genes from each of the six T6SS loci
were tested for virulence in a hamster infection model; only the
hcp1 mutant was attenuated for virulence (Burtnick et al., 2011).
The hcp1 mutant was taken up by RAW 264.7 macrophages at a
similar rate to the wild-type strain and could escape from phago-
somes into the cytosol and move intracellularly by actin-based
motility. Although the hcp1 mutant showed a reduced level of
actin-based motility and a delayed intracellular growth pheno-
type, by 18 h p.i. the levels of intracellular wild-type and hcp1
mutant bacteria were indistinguishable. Importantly, no MNGC
formation was observed in RAW 264.7 cells following infection
with the hcp1 mutant despite high levels of intracellular bacteria
(Table 1). These data suggest that a secreted effector(s) of the T6SS
is critical for the cell fusion of macrophages and for the formation
of MNGC. Indeed, Burtnick et al. (2011) proposed that the inabil-
ity of the hcp1 mutant to induce MNGC formation may lead
directly to its reduced intracellular growth defect, as the fusion
with nutrient rich, uninfected macrophages may be critical for the
intracellular replication of B. pseudomallei.
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A genome-wide screen for B. pseudomallei products which
could damage macrophage cells identiﬁed a wide range of B.
pseudomallei genes, including the putative toxin-encoding genes
bpsl0590 and bpsl0591 (Dowling et al., 2010). In this analysis, the
supernatants from cultures of E. coli containing B. pseudoma-
llei genomic fragments cloned in BAC or fosmid vectors, were
tested for activity against J774-2 macrophage cells. More than
110 genomic regions were identiﬁed as conferring some level of
anti-macrophage activity; however, the cloned genomic fragments
contained multiple genes and the anti-macrophage activity was
never localized to single genes. Importantly, treatment of J774-2
cells with supernatant from E. coli clones containing an approxi-
mately 15 kb region containing the genes bpsl0590 and bpsl0591,
directly caused apoptosis and the formation of MNGC, suggesting
that the putative toxins encoded by these genes may have a direct
role in MNGC formation.
The MNGC formed following B. pseudomallei infection of
macrophage-like cells show striking similarities to osteoclast cells,
which are also MNGC. MNGC resulting from B. pseudoma-
llei infection of RAW 264.7 cells express increased levels of
mRNAencoding each of the osteoclastmarkers calcitonin receptor
(CTR), cathepsin K (CTSK), and tartrate-resistant acid phos-
phatase (TRAP) compared to uninfected cells (Boddey et al.,
2007). Interestingly, while B. thailandensis also induces the for-
mation of MNGC, these cells do not express increased levels of
the osteoclast markers CTR and CTSK, and show only a mar-
ginal increase in TRAP expression (Boddey et al., 2007). The B.
pseudomallei gene lfpA (lactonase family protein A) was found to
be required for maximal stimulation of expression of osteoclast
markers in RAW 264.7 cells following B. pseudomallei infection;
this gene is not present in B. thailandensis. Expression of lfpA
itself was up-regulated approximately 107-fold in bacteria that
were in contact with RAW 264.7 cells as compared to those grow-
ing in vitro. A B. pseudomallei lfpA mutant was able to replicate
at levels indistinguishable from the wild-type strain in RAW 264.7
macrophage-like cells and form actin-tails, but showed reduced
virulence in both Syrian hamsters and BALB/c mice (Boddey
et al., 2007; Table 1). Taken together these data suggest that B.
pseudomallei speciﬁcally induces the formation of MNGC through
a number of mechanisms and the induction of these host cell
changes may have evolved to beneﬁt the bacteria as a niche for
optimal replication and spread.
INHIBITION OF MACROPHAGE ACTIVATION FACILITATES
INTRACELLULAR SURVIVAL
The ability of B. pseudomallei to survive and replicate in
macrophages is at least in part due to the suppression of
macrophage killing mechanisms, including the production of the
free radical species nitric oxide (NO), although it should be
noted that human macrophages produce less NO than rodent
macrophages (for review see Carsillo et al., 2009). NO is one of the
key antimicrobial molecules produced within macrophages and
is important for the clearance of many intracellular pathogens,
including Leishmania, Salmonella, and Mycobacterium (for review
see Fang, 1997). In macrophages, NO production results from
the activity of the inducible nitric oxide synthase (iNOS). Expres-
sion of iNOS is stimulated by the cytokines IFN-γ, IFN-β, TNFα,
IL-1, and IL-2, and by pathogen-associated products includ-
ing lipopolysaccharide (LPS) and lipoteichoic acid (Fang, 1997;
Jacobs and Ignarro, 2001). However, macrophages infected with
B. pseudomallei do not activate iNOS expression. This is due,
at least in part, to the inability of B. pseudomallei-infected
macrophages to produce IFN-γ and IFN-β, as stimulation of
infected macrophages with either of these interferons results in
increased iNOS expression and reduced intracellular survival of
B. pseudomallei (Utaisincharoen et al., 2003, 2004).
The secretion of IFN-β by macrophages is up-regulated in
response to LPS and also infection with Gram-negative, but
not Gram-positive, bacteria, suggesting that LPS is critical for
production of IFN-β (Utaisincharoen et al., 2003). The inabil-
ity of macrophages infected with B. pseudomallei to produce
IFN-β may be a direct consequence of the LPS structure of B.
pseudomallei (Utaisincharoen et al., 2003), as puriﬁed B. pseudo-
mallei LPS stimulated reduced NO expression in comparison
to macrophages stimulated with E. coli or Salmonella enterica
serovar Typhi LPS (Utaisincharoen et al., 2000). Furthermore, a
B. pseudomallei wbiI mutant, which is predicted to express LPS
lackingO-antigen, stimulated signiﬁcant levels of iNOS and IFN-β
production (Arjcharoen et al., 2007; Figure 1).
Both IFN-γ and IFN-β produce a transcriptional response
through the Janus kinases-signal transducers and activators
of transcription (JAK–STAT) signal transduction pathway. The
receptor complexes for each IFN type are related but unique
(Decker et al., 2002) and binding of IFN to the appropriate
receptor results in STAT phosphorylation and dimerization. IFN-
γ binding results in STAT-1 homodimerization, whereas IFN-β
results in production of phosphorylated STAT-1 homodimers and
STAT-1 and STAT-2 heterodimers. These phosphorylated STAT
dimers are then translocated into the nucleus where they medi-
ate changes in expression of a range of IFN-regulated genes
including iNOS. However, the suppressor of cytokine signal-
ing (SOCS) and cytokine-inducible Src homology 2-containing
(CIS) proteins can inhibit STAT phosphorylation and therefore
IFN responses (Ekchariyawat et al., 2005; Figure 1). RAW 264.7
macrophages exposed to either live or killed B. pseudomallei
showed increased expression of SOCS3 and CIS but not SOCS1
and 2 (Ekchariyawat et al., 2005). This activation was speciﬁ-
cally due to the presence of intracellular B. pseudomallei, rather
than a secondary response to macrophage cytokine production, as
increased SOCS3 andCISmRNAwas observed even following pre-
treatment of macrophages with the protein inhibitor cyclohexam-
ide (Ekchariyawat et al., 2005, 2007). Furthermore, up-regulation
of SOCS3 mRNA was not observed in a macrophage cell line with
reduced nucleotide-binding oligomerization domain-containing
protein 2 (NOD2) expression, suggesting that the cytoplasmic pat-
tern recognition receptor NOD2 is critical for SOCS3-mediated
inhibition of iNOS expression (Pudla et al., 2010).
EVASION OF HOST CELL AUTOPHAGIC MECHANISMS BY B.
PSEUDOMALLEI
Autophagy occurs in all eukaryotic cells and is critical for the reg-
ulated degradation of cellular components. During autophagy a
portion of cytoplasm becomes enclosed within an isolation mem-
brane (phagophore), generating a double-membrane vesicle, the
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autophagosome, which then, usually following initial fusion with
an endosome, fuses with a lysosome. The material sequestered
within the autophagosome is then degraded and the products
exported to the cytosol for re-use. Autophagy is important in the
context of cellular homeostasis for the removal and recycling of
damaged or non-functional organelles and the destruction of cer-
tain long-lived proteins and other macromolecules (Ravikumar
et al., 2010).
Recently, autophagy has become recognized as an important
component of the eukaryotic innate immune system (Schmid and
Munz, 2007; Ravikumar et al., 2010). In this context, autophagy
can function as a defense mechanism against bacterial pathogens,
resulting in their clearance. While some pathogens succumb to
autophagic clearance and others modify autophagy to beneﬁt their
intracellular survival, it is clear that still other intracellular bacte-
rial pathogens can evade autophagy to aid their survival (Hussey
et al., 2009; Shahnazari and Brumell, 2011). Notably, two bacterial
species, L. monocytogenes and S. ﬂexneri, which can disrupt the
phagosome membrane to allow escape into the cytosol, can be tar-
geted by autophagy (Ogawa et al., 2005; Birmingham et al., 2007)
when free in the cytosol.
AUTOPHAGY AND B. PSEUDOMALLEI
Bacterial escape fromphagosomes, and the prospect of the escaped
bacteria being subject to autophagy, led us to carry out the
ﬁrst analyses of the interaction of B. pseudomallei with host cell
autophagic processes. In response to infection of macrophage
RAW 264.7 cells, only a subset of bacteria co-localized with
the autophagy marker protein LC3 (Cullinane et al., 2008).
When cells were treated with rapamycin, a pharmacological
inducer of autophagy, bacterial co-localization with LC3 was
increased signiﬁcantly and bacterial survival was reduced. Thus,
autophagy was implicated as part of the host defense system
against B. pseudomallei infection, although the mechanism by
which most invading bacteria avoided host autophagic attack
remained obscure. Moreover, we showed that the predicted bacte-
rial Bsa T3SS effector protein, BopA, is involved in modulating the
host cell response, as bopA mutant bacteria showed increased co-
localizationwithLC3and reduced intracellular survival (Cullinane
et al., 2008).
Recently it was shown that LC3 can be recruited directly
to bacteria-containing phagosomes (Sanjuan et al., 2007) via a
process designated LC3-associated phagocytosis (LAP; Sanjuan
et al., 2009). In RAW 264.7 cells infected with E. coli, LAP
was induced by LPS treatment via toll-like receptors (TLRs),
and involved the rapid translocation of the autophagic proteins
Beclin1 and LC3 to the bacteria-containing phagosomes, lead-
ing to an increased level of phagocytosis and bacterial killing
(Sanjuan et al., 2007). These reports led us to assess the nature
of the compartment in which intracellular B. pseudomallei is
sequestered. Through an extensive analysis of EM images of
infected cells, we demonstrated that intracellular bacteria are
either free in the cytosol or sequestered in single-membrane
phagosomes, but only extremely rarely contained in double-
membrane autophagosomes, suggesting that LC3 is recruited
to B. pseudomallei-containing phagosomes (Gong et al., 2011;
Figure 2).
Quantitative analysis of EM images of a bipD mutant, lacking
a functional Bsa T3SS, indicated that it displayed no escape from
phagosomes at 2 and 4 h p.i. However, bipD mutant bacteria dis-
played a high level of co-localization with LC3. Furthermore, bopA
mutant bacteria that display increased co-localization with LC3
(Cullinane et al., 2008) also showed reduced phagosome escape
(Gong et al., 2011). These observations indicate that B. pseudoma-
llei co-localizationwith LC3occurs as a result of direct recruitment
of LC3 to phagosomes that contain bacteria and is not due to
engulfment of bacteria by canonical autophagosomes (Figure 2).
Recruitment of LC3 to phagosomes in LAP led to their rapid
acidiﬁcation and enhanced killing of ingested E. coli in RAW 264.7
cells (Sanjuan et al., 2007, 2009). In our experiments, both bipD
and bopA mutant bacteria showed decreased intracellular survival,
enhanced co-localization with LC3 and entrapment in phago-
somes (Gong et al., 2011). To conﬁrm that these observations
were consistent with LAP, we determined the dual co-localization
of bacteria with LC3 and the lysosome marker LAMP-1. Such dual
co-localization serves as a measure of the maturation of bacteria-
containing LC3+ phagosomes by fusion with lysosomes. The per-
centage of bacteria co-localized with both LC3 and LAMP-1 was
signiﬁcantly higher for both mutants, suggesting that LC3 recruit-
ment is associatedwith enhanced levels of phagolysosomematura-
tion. Consistent with this proposal was the observation that only
a very low percentage of LC3− bacteria-containing phagosomes
were LAMP-1+. On the basis of these data we propose that LC3
recruitment toB. pseudomallei-containing phagosomes stimulates
fusion of phagosomes with lysosomes, leading to enhanced killing
of the internalized bacteria. However, this hypothesis remains to
be demonstrated directly.
Collectively these observations (Gong et al., 2011) show that
LAP, rather than canonical autophagy, is the mechanism which
macrophage cells use in defense against B. pseudomallei infection.
However LAP is relatively ineffective and most bacteria escape
to the cytosol where they efﬁciently evade capture by canonical
autophagy (Figure 2).
ESCAPE FROM AUTOPHAGY OCCURS BY A MECHANISM DIFFERENT
FROM THAT USED BY SHIGELLA
Shigella ﬂexneri induces membrane damage to mediate bacter-
ial escape from the phagosome into the cytosol, where it induces
actin polymerization, mediated by the bacterial IcsA (VirG) pro-
tein (Makino et al., 1986; Goldberg and Theriot, 1995). In some
cell types IcsA is speciﬁcally targeted by the autophagic mem-
brane protein Atg5, thereby inducing autophagy (Ogawa et al.,
2005). However, S. ﬂexneri secretes a T3SS effector protein, IcsB,
which binds to IcsA and competitively inhibits its interaction with
Atg5, thus abrogating the induction of autophagy (Ogawa et al.,
2005). Interestingly, B. pseudomallei encodes the proteins BimA
and BopA which have 11 and 23% amino acid identity respectively
to their S. ﬂexneri homologs, IcsA and IcsB.
Although BimA mediates actin-based intracellular motility of
B. pseudomallei (Stevens et al., 2005b), it lacks the IcsA-binding
domain targeted by Atg5 (Ogawa et al., 2005). Thus, it would seem
that BimA and IcsA are not functional counterparts in the context
of autophagy evasion. Furthermore, bacterial two-hybrid analysis
(our unpublished data) failed to establish an interaction between
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FIGURE 2 | Possible fates of B. pseudomallei in infected macrophages.
Following phagocytic uptake by macrophages, bacteria are ﬁrst located within
phagosomes. The majority of wild-type bacteria can escape from the
phagosome into the cytosol (pathway B) in a process which is largely
uncharacterized but involves the BsaT3SS. Once free in the cytosol bacteria
activate BimA-mediated actin-based motility and replicate (pathway C).
Potentially some cytosolic bacteria may be sequestered in canonical
autophagosomes (pathway D), but the available evidence suggests that this
occurs very infrequently. The autophagy marker protein LC3 can be
recruited to bacteria-containing phagosomes, a process designated
LC3-associated phagocytosis (LAP) which stimulates further
phagosomal maturation via recruitment of other proteins, and the
subsequent fusion of phagosomes with lysosomes, leading to
bacterial killing (pathway A). It is possible that bacteria may
escape from LAP, but deﬁnitive evidence that this occurs is presently
lacking.
BopA and BimA, suggesting that the B. pseudomallei proteins do
not interact in a manner comparable to their S. ﬂexneri counter-
parts. Thus, we propose that B. pseudomallei evades autophagy by
an alternative mechanism which currently remains unknown.
UBIQUITINATION-MEDIATED AUTOPHAGY
The speciﬁc modiﬁcation of cellular proteins with polyubiquitin
is a fundamental post-translational modiﬁcation that occurs in all
eukaryotic cells and is central to many cellular processes. Depend-
ing on the nature of the modiﬁcation (K48- or K63-linked chains)
polyubiquitination can result in altered functional properties, in
targeting the protein for degradation by the 26S proteasome, or
as shown recently, targeting of the material for lysosomal degra-
dation by the autophagic pathway (for review see Komatsu and
Ichimura, 2010).
Ubiquitination involves the conjugation of ubiquitin (Ub)
moieties to target proteins. In mammalian cells, ubiquitination
involves three enzymatic steps. Ub-activating enzymes (E1) trans-
fer Ub to E2-conjugating enzymes, which then transfer the acti-
vated Ub to a lysine of the target protein through E3 ligases
(Shabek and Ciechanover, 2010). Deubiquitinases are responsible
for removing Ub chains from proteins (Shabek and Ciechanover,
2010).
The ubiquitination pathway does not operate in prokary-
otes. Nevertheless, polyubiquitination has been shown in many
cases to be important for regulating the host response to
pathogens. Exploitation of host ubiquitination signaling pathways
by pathogen effectors appears to be a common theme among bac-
teria (for review see Angot et al., 2007). A number of pathogen
tactics has been described; they include effectors secreted by Type
III and Type VI systems that (i) use the host ubiquitin proteasome
system (UPS) to assure their own destruction; (ii) interfere with
the ubiquitination level of key cellular proteins involved in innate
immunity, or (iii) mimic E3 ligase subunits to manipulate the UPS
to its own advantage.
A recent report suggests that, like a number of other pathogens,
B. pseudomallei can modulate host ubiquitination to its own
advantage. TssM, a secreted product of the T6SS cluster 5 encoded
by the bpss1512 gene, was identiﬁed as a virulence factor for B.
pseudomallei (Tan et al., 2010). In an acute BALB/c mouse infec-
tion model, the absence of TssM in B. pseudomallei increased the
rate of death and inﬂammation in infected mice. TssM was alone
found to be responsible for down-regulating host inﬂammatory
responses by interfering with the ubiquitination of critical signal-
ing intermediates and, in turn, the activation of NF-κB. Overex-
pression of TssM in HEK293T cells resulted in diminished ubiq-
uitinated forms of TNFR-associated factor-3, TNFR-associated
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factor-6 and IκBα. The attenuation of NF-κB activity observed in
macrophages infected with wild-type B. pseudomallei was restored
in macrophages infected with a tssM mutant.
BPSS1512 shares 99% identity with TssM of B. mallei. In an
earlier study it was shown that tssM encodes a broad-based deu-
biquitinase (Shanks et al., 2009). Cleavage of both K48- and
K63-linked ubiquitinated substrates was demonstrated in enzy-
matic assays. In this study no cellular substrates or phenotype
in animal models could be identiﬁed. Nevertheless, collectively
these studies of TssM indicate that B. pseudomallei is able to
modulate the host ubiquitination system through the action of
a secreted deubiquitinase. It remains to be seen whether other
host or bacterial substrates exist for the deubiquitinase activity
of TssM, or whether B. pseudomallei can secrete other effectors
capable of modulating the host Ub-pathway. Since several tar-
get cytosolic proteins are subject to the deubiquitinase activity of
TssM, it seems likely that other cytosolic host proteins may well be
susceptible.
It has been suggested that Ub-mediated targeting is a gen-
eral and major pathway of selective autophagy in mammals. One
possible set of targets for the deubiquitinase activity of TssM,
yet to be investigated, are ubiquitinated proteins associated with
bacteria and recognized by the autophagic pathway. There are sev-
eral reports describing the co-localization with polyubiquitin of
bacteria that have escaped from the phagosome. Species include
Streptococcus pyogenes,L. monocytogenes, andMycobacteriummar-
inum (for review see Shahnazari and Brumell, 2011). A model has
been proposed in which host or bacterial proteins associated with
the bacterial surface are directly ubiquitinated by the host sys-
tem. However, the identity of the ubiquitinated proteins has yet
to be established. An alternate model has been proposed, based
on observations of S. ﬂexneri infections. When S. ﬂexneri disrupts
the phagosome membrane to escape into the cytosol, proteins
associated with membrane remnants, including TRAF6 which is
involved in NF-κB signaling, are polyubiquitinated, recruit the
autophagymarker LC3 and adaptor p62, and are targeted to degra-
dation through autophagy (Dupont et al., 2009). The presence of
both P62 and other IKK components trapped in the membrane
remnants led to the suggestion that the autophagy pathway is used
to regulate the activation of inﬂammatory responses at early time-
points in infection (Dupont et al., 2009). Notably, in autophagy
deﬁcient (Atg5−/−) cells and in cells in which autophagosome
maturation was blocked (ATG4B dominant negative mutant),
polyubiquitinated proteins and P62 accumulated on membrane
remnants, and the early inﬂammatory and cytokine response was
exacerbated (Dupont et al., 2009). Our preliminary data show that
B. pseudomallei in macrophages do not show a high degree of co-
localization with poly-Ub, suggesting that the host ubiquitination
pathway might be modulated at a number of levels. One intriguing
possibility is that the deubiquitinase activity of the TssM effector
may play a role in removing Ub from proteins associated with the
bacterial surface, thereby allowing the bacteria to avoid detection
and elimination from the host cell by autophagy.
Burkholderia pseudomallei K96243 encodes a cyclomodulin
(BPSS1385) that displays 26% identity with the cycle inhibit-
ing factor (Cif) cyclomodulin produced by enteropathogenic and
enterohemorrhagic E. coli (Jubelin et al., 2009;Yao et al., 2009). Cif
from pathogenic E. coli is an effector which is injected into host
cells via the T3SS machinery and provokes an irreversible cyto-
pathic effect which is characterized by G1 and G2 cell cycle arrests
and reorganization of the actin network (Nougayrède et al., 2001;
Marchès et al., 2003; Taieb et al., 2006; Samba-Louaka et al., 2008;
Jubelin et al., 2009). The B. pseudomallei cyclomodulin, termed
CHBP (for Cif homolog in Burkholderia pseudomallei), reveals a
papain-like fold with a conserved Cys-His-Gln catalytic triad and
has been shown to be a functional homolog of Cif from E. coli
(Jubelin et al., 2009; Yao et al., 2009). Interestingly, it was recently
shown that CHBP is a potent inhibitor of the eukaryotic ubiqui-
tination pathway and speciﬁcally deamidates Gln40 in ubiquitin
and NEDD8 (a ubiquitin-like protein) and in turn attenuates
ubiquitination both in vitro and during Burkholderia infection
(Cui et al., 2010). Notably, CHBP was recognized by melioidosis
patient serum (Felgner et al., 2009). At present there is no evidence
to connect these observations concerning CHBP with the function
of host autophagic pathways.
In summary, there is a number of intriguing observations
that suggest a role for ubiquitin signaling and the avoidance
of host autophagy in response to infection by B. pseudomallei.
However, a more integrated understanding must await further
experimentation.
CONCLUDING REMARKS
Burkholderia pseudomallei has evolved a large array of mechanisms
to survive and replicate within eukaryotic cells, including mam-
malian phagocytic and non-phagocytic cells. As we have outlined
in this review, the last twodecades have seen signiﬁcant advances in
the elucidation of these mechanisms. However, much remains to
be uncovered about the detailed interaction of bacterial and host
cell factors at the molecular level. The apparently unique mecha-
nism of actin-based motility in B. pseudomallei remains obscure.
Likewise,many aspects of the roles of the three T3SS clusters in the
interaction of bacterial and host cell molecules and their poten-
tial cross-talk remain to be deﬁned. The possibility exists that the
different clusters are involved in the invasion of, and replication
within, different types of mammalian cells. The precise function
of the six T6SS clusters also requires further investigation. While
it is clear that most B. pseudomallei in cells are able to escape
autophagic attack, the mechanisms are presently unknown. The
possibility of host ubiquitination of the bacterial cell surface and
whetherB. pseudomallei possesses strategies to combat this process
are currently under investigation.
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